BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32192794)

  • 1. Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia.
    Stein F; Lemmer G; Schmitt S; Brosch K; Meller T; Fischer E; Kraus C; Lenhard L; Köhnlein B; Murata H; Bäcker A; Müller M; Franz M; Förster K; Meinert S; Enneking V; Koch K; Grotegerd D; Nagels A; Nenadić I; Dannlowski U; Kircher T; Krug A
    Schizophr Res; 2020 Apr; 218():38-47. PubMed ID: 32192794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of illness-dependent associations of neuro-cognition and psychopathological syndromes in a large transdiagnostic cohort.
    Stein F; Schmitt S; Brosch K; Meller T; Pfarr JK; Ringwald K; Lemmer G; Philipsen A; Meinert S; Lemke H; Waltemate L; Thiel K; Franz M; Preuss UW; Metzger FG; Nagels A; Nenadić I; Dannlowski U; Kircher T; Krug A
    J Affect Disord; 2023 Mar; 324():589-599. PubMed ID: 36586619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes.
    Stein F; Meller T; Brosch K; Schmitt S; Ringwald K; Pfarr JK; Meinert S; Thiel K; Lemke H; Waltemate L; Grotegerd D; Opel N; Jansen A; Nenadić I; Dannlowski U; Krug A; Kircher T
    Schizophr Bull; 2021 Oct; 47(6):1740-1750. PubMed ID: 33860786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor analysis of lifetime psychopathology and its brain morphometric and genetic correlates in a transdiagnostic sample.
    Krug A; Stein F; David FS; Schmitt S; Brosch K; Pfarr JK; Ringwald KG; Meller T; Thomas-Odenthal F; Meinert S; Thiel K; Winter A; Waltemate L; Lemke H; Grotegerd D; Opel N; Repple J; Hahn T; Streit F; Witt SH; Rietschel M; Andlauer TFM; Nöthen MM; Philipsen A; Nenadić I; Dannlowski U; Kircher T; Forstner AJ
    Transl Psychiatry; 2024 Jun; 14(1):235. PubMed ID: 38830892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
    David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
    Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features.
    Salvatore P; Baldessarini RJ; Khalsa HM; Amore M; Di Vittorio C; Ferraro G; Maggini C; Tohen M
    J Clin Psychiatry; 2013 Jul; 74(7):723-31; quiz 731. PubMed ID: 23945450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of item level negative symptoms in first episode psychosis diagnoses.
    Lyne J; O'Donoghue B; Owens E; Renwick L; Madigan K; Kinsella A; Clarke M; Turner N; O'Callaghan E
    Schizophr Res; 2012 Mar; 135(1-3):128-33. PubMed ID: 22281102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathology factors in first-episode affective and non-affective psychotic disorders.
    Salvatore P; Khalsa HM; Hennen J; Tohen M; Yurgelun-Todd D; Casolari F; Depanfilis C; Maggini C; Baldessarini RJ
    J Psychiatr Res; 2007 Nov; 41(9):724-36. PubMed ID: 16762370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Structural Network Connectivity of Formal Thought Disorder Dimensions in Affective and Psychotic Disorders.
    Stein F; Gruber M; Mauritz M; Brosch K; Pfarr JK; Ringwald KG; Thomas-Odenthal F; Wroblewski A; Evermann U; Steinsträter O; Grumbach P; Thiel K; Winter A; Bonnekoh LM; Flinkenflügel K; Goltermann J; Meinert S; Grotegerd D; Bauer J; Opel N; Hahn T; Leehr EJ; Jansen A; de Lange SC; van den Heuvel MP; Nenadić I; Krug A; Dannlowski U; Repple J; Kircher T
    Biol Psychiatry; 2024 Apr; 95(7):629-638. PubMed ID: 37207935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are positive and negative symptoms relevant to cross-sectional diagnosis of schizophrenic and schizoaffective patients?
    Cuesta MJ; Peralta V
    Compr Psychiatry; 1995; 36(5):353-61. PubMed ID: 7497709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).
    Reininghaus U; Böhnke JR; Chavez-Baldini U; Gibbons R; Ivleva E; Clementz BA; Pearlson GD; Keshavan MS; Sweeney JA; Tamminga CA
    World Psychiatry; 2019 Feb; 18(1):67-76. PubMed ID: 30600629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study.
    Correa-Ghisays P; Sánchez-Ortí JV; Balanzá-Martínez V; Selva-Vera G; Vila-Francés J; Magdalena-Benedito R; Victor VM; Escribano-López I; Hernández-Mijares A; Vivas-Lalinde J; San-Martín C; Crespo-Facorro B; Tabarés-Seisdedos R
    J Affect Disord; 2022 Mar; 300():99-108. PubMed ID: 34965401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis.
    Craig T; Hwang MY; Bromet EJ
    Am J Psychiatry; 2002 Apr; 159(4):592-8. PubMed ID: 11925297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight and symptom change in schizophrenia and other disorders.
    Weiler MA; Fleisher MH; McArthur-Campbell D
    Schizophr Res; 2000 Sep; 45(1-2):29-36. PubMed ID: 10978870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Kingston T; Scully PJ; Browne DJ; Baldwin PA; Kinsella A; O'Callaghan E; Russell V; Waddington JL
    CNS Neurosci Ther; 2018 Jul; 24(7):633-640. PubMed ID: 29575682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression.
    Maj M; Starace F; Pirozzi R
    Am J Psychiatry; 1991 May; 148(5):612-6. PubMed ID: 2018162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.
    Regenold WT; Thapar RK; Marano C; Gavirneni S; Kondapavuluru PV
    J Affect Disord; 2002 Jun; 70(1):19-26. PubMed ID: 12113916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.